Trasplante de corazón a partir de donante positivo a SARS-CoV-2. Primer caso en México

IF 0.3 Q4 SURGERY Cirugia Cardiovascular Pub Date : 2024-01-01 DOI:10.1016/j.circv.2023.01.001

Guillermo Careaga-Reyna , Hugo Jesús Zetina-Tun , Leticia Arizbeth Hernández-Castro , Hugo Arturo Álvarez-Alvarado , Aidé Saraí de la Cruz-Domínguez , Luis Manuel Álvarez-Sáncheza

{"title":"Trasplante de corazón a partir de donante positivo a SARS-CoV-2. Primer caso en México","authors":"Guillermo Careaga-Reyna , Hugo Jesús Zetina-Tun , Leticia Arizbeth Hernández-Castro , Hugo Arturo Álvarez-Alvarado , Aidé Saraí de la Cruz-Domínguez , Luis Manuel Álvarez-Sáncheza","doi":"10.1016/j.circv.2023.01.001","DOIUrl":null,"url":null,"abstract":"<div><p>The COVID-19 pandemic affected transplant programs by decreasing the number of procedures performed. Although they have already restarted, the lack of donors is a limitation, given the possibility of transmission of the virus. Currently, transplants have been performed under special conditions from SARS-CoV-2 positive donors. We present the case of a 58-year-old male patient with refractory heart failure secondary to residual postinfarction interventricular septal defect who received heart from a 16-year-old asymptomatic, SARS-CoV-2-positive donor. The procedure was performed without complications, with favorable postoperative evolution, discharged 15 days posttransplant. Currently asymptomatic and with no evidence of SARS-CoV-2 infection. This is the first case in Mexico carried out under these conditions.</p></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"31 1","pages":"Pages 21-24"},"PeriodicalIF":0.3000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1134009623000013/pdfft?md5=6a9bbb04604dac753e203c7e01f42a6e&pid=1-s2.0-S1134009623000013-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cirugia Cardiovascular","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134009623000013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

The COVID-19 pandemic affected transplant programs by decreasing the number of procedures performed. Although they have already restarted, the lack of donors is a limitation, given the possibility of transmission of the virus. Currently, transplants have been performed under special conditions from SARS-CoV-2 positive donors. We present the case of a 58-year-old male patient with refractory heart failure secondary to residual postinfarction interventricular septal defect who received heart from a 16-year-old asymptomatic, SARS-CoV-2-positive donor. The procedure was performed without complications, with favorable postoperative evolution, discharged 15 days posttransplant. Currently asymptomatic and with no evidence of SARS-CoV-2 infection. This is the first case in Mexico carried out under these conditions.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

来自SARS-CoV-2阳性供体的心脏移植。墨西哥首例病例

COVID-19 大流行影响了移植计划，减少了移植手术的数量。尽管这些计划已经重新启动，但由于病毒传播的可能性，供体的缺乏仍是一个限制因素。目前，已在特殊条件下对 SARS-CoV-2 阳性供体进行了移植。我们介绍了一例因梗死后室间隔缺损残留而继发难治性心力衰竭的 58 岁男性患者，他接受了来自 16 岁无症状、SARS-CoV-2 阳性供体的心脏。手术过程无并发症，术后恢复良好，移植后 15 天出院。目前无症状，无 SARS-CoV-2 感染迹象。这是墨西哥首例在这种情况下进行的移植手术。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊